Amgen Director Omar Ishrak Receives 665 RSU Shares Valued at $0

This SEC Form 4 filing reports that Omar Ishrak, a director of Amgen Inc., acquired 665 shares of common stock through vested Restricted Stock Units (RSUs) on May 19, 2026. The shares were granted at $0 per share under the company's 2009 Director Incentive Program and Second Amended and Restated 2009 Equity Incentive Plan. Following this transaction, Ishrak's total holdings increased to 7,358.7361 shares. The filing notes that the RSUs vested immediately and are paid in shares on a one-to-one basis, with directors having the option to defer payment according to an elected schedule. The transaction represents routine equity compensation for board members rather than market purchases.